Characterization and chlorine reactivity of particulate matter released by bathers in indoor swimming pools.

Disinfecting swimming pool water is essential for preventing waterborne diseases. An unforeseen consequence of treating water with disinfectants is the formation of disinfection by-products (DPBs) that can cause harmful effects to health through the interactions between the added disinfectant and organic matter in the water. The present work focuses on the chlorine reactivity with particles released by bathers. Such particles are collected in the filter backwash water of swimming pools and this study intends to distinguish DPBs generated from dissolved chemicals from those formed by particulate matter. Therefore, filtered and unfiltered backwash waters were collected from several swimming pools, analysed physicochemically and chemically, and then chlorinated as is (79 mgL-1) and as diluted suspensions (36.2 and 11.9 mgL-1) at varying concentrations of chlorine (1.2 mg and 24 mgCl2L-1). Utilizing a DPD colorimetric technique and GC-ECD, respectively, the kinetics of chlorine consumption and DPBs production have been investigated. Up to 25.7 µgL-1 of chloroform was produced within 96 h at 1.2 mgCl2L-1, followed by haloacetic acids (HAAs) and haloacetonitriles (HANs). Within 96 h, the concentration of trichloroacetic acid reached a maximum of 231.8 µgL-1 at a chlorine concentration of 231.8 µgL-1. The formations of 0.13 µmol THMs, 0.31 µmol HAAs, and 0.04 µmol HANs per mg of dissolved organic carbon (DOC) were finally determined by correlating the organic content of particles with the nature of the DBPs generated. Comparing the quantities of DBPs generated in filtered and unfiltered samples helps us conclude that ∼50% of DBPs formed during the chlorination of swimming pool water are derived from particles brought by bathers.

Impurity profiling of trandolapril under stress testing: Structure elucidation of by-products and development of degradation pathway.

Various regulatory authorities like International Conference on Harmonization (ICH), US Food and Drug Administration, Canadian Drug and Health Agency are emphasizing on the purity requirements and the identification of impurities in active pharmaceutical drugs. Qualification of the impurities is the process of acquiring and evaluating data that establishes biological safety of an individual impurity; thus, revealing the need and scope of impurity profiling of drugs in pharmaceutical research. As no stability-indicating method is available for identification of degradation products of trandolapril, a new angiotensin converting enzyme inhibitor (ACEI), under stress testing, the development of an accurate method is needed for quantification and qualification of degradation products. Ultra high performance liquid chromatography (UPLC) coupled to electrospray tandem mass spectrometry was used for the rapid and simultaneous analysis of trandolapril and its degradation products. Chromatographic separation was achieved in less than 4 min, with improved peak resolution and sensitivity. Thanks to this method, the kinetics of trandolapril degradation under various operating conditions and the characterization of the structure of the by-products formed during stress testing have been determined. Thereafter, a mechanism of trandolapril degradation in acid and neutral conditions, including all the identified products, was then proposed.